Trial Profile
A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Aug 2012
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary) ; Carboplatin; Cisplatin; Docetaxel; Gemcitabine; Irinotecan; Paclitaxel; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use